Antibiotic resistance needs global solutions
Based on these data, we estimated the disease-specific burden in sub-Saharan African children in 2005 by applying the admission rates,4 risk per admission, case-fatality ratio, and impact per case3 determined at this site for regional child population estimates.5 On the basis of these assessments, n...
Gespeichert in:
| Veröffentlicht in: | The Lancet infectious diseases 2014-07, Vol.14 (7), p.550-551 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 551 |
|---|---|
| container_issue | 7 |
| container_start_page | 550 |
| container_title | The Lancet infectious diseases |
| container_volume | 14 |
| creator | Aiken, Alexander M Allegranzi, Benedetta Scott, J Anthony Mehtar, Shaheen Pittet, Didier Grundmann, Hajo |
| description | Based on these data, we estimated the disease-specific burden in sub-Saharan African children in 2005 by applying the admission rates,4 risk per admission, case-fatality ratio, and impact per case3 determined at this site for regional child population estimates.5 On the basis of these assessments, nosocomial bacteraemia could have accounted for 25 000 deaths and 270 000 additional inpatient days in African children in 2005. |
| doi_str_mv | 10.1016/S1473-3099(14)70709-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_1539282642</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309914707091</els_id><sourcerecordid>3346333831</sourcerecordid><originalsourceid>FETCH-LOGICAL-c550t-9dd29f6c641a4b4345176e39d2970859c1766efe4449bf6200d44f00464139c13</originalsourceid><addsrcrecordid>eNqFkE1P5DAMhqMVaPnan7BoJC6LRBenddPJBYQQXxLSHoCz1aYuBEoDSQdp_v2m0-HzwsmJ_fq1_QjxW8JfCVLtX0kssiQDrf9I3C2gAJ3IH2I9pjFBzIuVxXuUrImNEO4BZCEBf4q1FLVCjbAu9o663lbW9dZMPAcb-rIzPOmY6zC5bV1VtpPg2llvXRe2xGpTtoF_LeOmuDk9uT4-Ty7_nV0cH10mJs-hT3Rdp7pRRqEsscIMc1koznTMFjDNtYlfxQ0joq4alQLUiA0AxoYsVrNNcTD6Ps2qR64Nd70vW3ry9rH0c3Klpc-Vzt7RrXshNS1SzCEa7CwNvHuecejp3s18F3cmmWc6naYK06jKR5XxLgTPzdsECTRApgVkGgiSRFpApmG97Y_rvXW9Uo2Cw1HAEdKLZU_BWI5ca-vZ9FQ7--2Igy8OprWdNWX7wHMO79dQSAlGk8EjxsFBZv8BpXifrA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1539282642</pqid></control><display><type>article</type><title>Antibiotic resistance needs global solutions</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>ProQuest Central UK/Ireland</source><creator>Aiken, Alexander M ; Allegranzi, Benedetta ; Scott, J Anthony ; Mehtar, Shaheen ; Pittet, Didier ; Grundmann, Hajo</creator><creatorcontrib>Aiken, Alexander M ; Allegranzi, Benedetta ; Scott, J Anthony ; Mehtar, Shaheen ; Pittet, Didier ; Grundmann, Hajo</creatorcontrib><description>Based on these data, we estimated the disease-specific burden in sub-Saharan African children in 2005 by applying the admission rates,4 risk per admission, case-fatality ratio, and impact per case3 determined at this site for regional child population estimates.5 On the basis of these assessments, nosocomial bacteraemia could have accounted for 25 000 deaths and 270 000 additional inpatient days in African children in 2005.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(14)70709-1</identifier><identifier>PMID: 24964940</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Animals ; Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - adverse effects ; Antibiotic resistance ; Antibiotics ; Antimicrobial agents ; Developing countries ; Disease ; Drug resistance ; Drug Resistance, Microbial ; Humans ; Infections ; Infectious Disease ; Infectious diseases ; LDCs ; Low income groups ; Mortality ; Nosocomial infection</subject><ispartof>The Lancet infectious diseases, 2014-07, Vol.14 (7), p.550-551</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Jul 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c550t-9dd29f6c641a4b4345176e39d2970859c1766efe4449bf6200d44f00464139c13</citedby><cites>FETCH-LOGICAL-c550t-9dd29f6c641a4b4345176e39d2970859c1766efe4449bf6200d44f00464139c13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1539282642?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64389,72341</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24964940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aiken, Alexander M</creatorcontrib><creatorcontrib>Allegranzi, Benedetta</creatorcontrib><creatorcontrib>Scott, J Anthony</creatorcontrib><creatorcontrib>Mehtar, Shaheen</creatorcontrib><creatorcontrib>Pittet, Didier</creatorcontrib><creatorcontrib>Grundmann, Hajo</creatorcontrib><title>Antibiotic resistance needs global solutions</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>Based on these data, we estimated the disease-specific burden in sub-Saharan African children in 2005 by applying the admission rates,4 risk per admission, case-fatality ratio, and impact per case3 determined at this site for regional child population estimates.5 On the basis of these assessments, nosocomial bacteraemia could have accounted for 25 000 deaths and 270 000 additional inpatient days in African children in 2005.</description><subject>Animals</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - adverse effects</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Antimicrobial agents</subject><subject>Developing countries</subject><subject>Disease</subject><subject>Drug resistance</subject><subject>Drug Resistance, Microbial</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>LDCs</subject><subject>Low income groups</subject><subject>Mortality</subject><subject>Nosocomial infection</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkE1P5DAMhqMVaPnan7BoJC6LRBenddPJBYQQXxLSHoCz1aYuBEoDSQdp_v2m0-HzwsmJ_fq1_QjxW8JfCVLtX0kssiQDrf9I3C2gAJ3IH2I9pjFBzIuVxXuUrImNEO4BZCEBf4q1FLVCjbAu9o663lbW9dZMPAcb-rIzPOmY6zC5bV1VtpPg2llvXRe2xGpTtoF_LeOmuDk9uT4-Ty7_nV0cH10mJs-hT3Rdp7pRRqEsscIMc1koznTMFjDNtYlfxQ0joq4alQLUiA0AxoYsVrNNcTD6Ps2qR64Nd70vW3ry9rH0c3Klpc-Vzt7RrXshNS1SzCEa7CwNvHuecejp3s18F3cmmWc6naYK06jKR5XxLgTPzdsECTRApgVkGgiSRFpApmG97Y_rvXW9Uo2Cw1HAEdKLZU_BWI5ca-vZ9FQ7--2Igy8OprWdNWX7wHMO79dQSAlGk8EjxsFBZv8BpXifrA</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Aiken, Alexander M</creator><creator>Allegranzi, Benedetta</creator><creator>Scott, J Anthony</creator><creator>Mehtar, Shaheen</creator><creator>Pittet, Didier</creator><creator>Grundmann, Hajo</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>20140701</creationdate><title>Antibiotic resistance needs global solutions</title><author>Aiken, Alexander M ; Allegranzi, Benedetta ; Scott, J Anthony ; Mehtar, Shaheen ; Pittet, Didier ; Grundmann, Hajo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c550t-9dd29f6c641a4b4345176e39d2970859c1766efe4449bf6200d44f00464139c13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - adverse effects</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Antimicrobial agents</topic><topic>Developing countries</topic><topic>Disease</topic><topic>Drug resistance</topic><topic>Drug Resistance, Microbial</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>LDCs</topic><topic>Low income groups</topic><topic>Mortality</topic><topic>Nosocomial infection</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aiken, Alexander M</creatorcontrib><creatorcontrib>Allegranzi, Benedetta</creatorcontrib><creatorcontrib>Scott, J Anthony</creatorcontrib><creatorcontrib>Mehtar, Shaheen</creatorcontrib><creatorcontrib>Pittet, Didier</creatorcontrib><creatorcontrib>Grundmann, Hajo</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>ProQuest Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>ProQuest Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aiken, Alexander M</au><au>Allegranzi, Benedetta</au><au>Scott, J Anthony</au><au>Mehtar, Shaheen</au><au>Pittet, Didier</au><au>Grundmann, Hajo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic resistance needs global solutions</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>14</volume><issue>7</issue><spage>550</spage><epage>551</epage><pages>550-551</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>Based on these data, we estimated the disease-specific burden in sub-Saharan African children in 2005 by applying the admission rates,4 risk per admission, case-fatality ratio, and impact per case3 determined at this site for regional child population estimates.5 On the basis of these assessments, nosocomial bacteraemia could have accounted for 25 000 deaths and 270 000 additional inpatient days in African children in 2005.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>24964940</pmid><doi>10.1016/S1473-3099(14)70709-1</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2014-07, Vol.14 (7), p.550-551 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_proquest_journals_1539282642 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete; ProQuest Central UK/Ireland |
| subjects | Animals Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - adverse effects Antibiotic resistance Antibiotics Antimicrobial agents Developing countries Disease Drug resistance Drug Resistance, Microbial Humans Infections Infectious Disease Infectious diseases LDCs Low income groups Mortality Nosocomial infection |
| title | Antibiotic resistance needs global solutions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T17%3A41%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20resistance%20needs%20global%20solutions&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Aiken,%20Alexander%20M&rft.date=2014-07-01&rft.volume=14&rft.issue=7&rft.spage=550&rft.epage=551&rft.pages=550-551&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(14)70709-1&rft_dat=%3Cproquest_pubme%3E3346333831%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1539282642&rft_id=info:pmid/24964940&rft_els_id=S1473309914707091&rfr_iscdi=true |